Literature DB >> 22555571

Assessment of salivary gland dysfunction after radioiodine therapy for thyroid carcinoma using non-contrast-enhanced CT: the significance of changes in volume and attenuation of the glands.

B Nabaa1, K Takahashi, T Sasaki, A Okizaki, T Aburano.   

Abstract

BACKGROUND AND
PURPOSE: Although radiation induced damage to the salivary gland is a known complication of radioactive iodine ((131)I) therapy for thyroid carcinoma, prediction of the severity and reversibility of sialoadenitis is difficult. Our aim was to correlate the extent of salivary dysfunction assessed by salivary gland scintigraphy with changes in the volume and attenuation of salivary glands on nonenhanced CT in postoperative patients with thyroid cancer treated with RIT.
MATERIALS AND METHODS: Forty patients with thyroid carcinoma, 13 men (age range, 21-80 years) and 27 women (age range, 28-75 years) who underwent a total thyroidectomy and were treated with RIT were assessed retrospectively. On CT, the percentage of volume reduction and the difference in attenuation of the parotid and submandibular glands after RIT were determined and correlated with the extent of radiation-induced salivary dysfunction on scintigraphy.
RESULTS: The salivary gland volume significantly decreased with an increase in the dysfunction grade on scintigraphy for both the parotid and submandibular glands (P < .001). The attenuation significantly increased with an increase in the dysfunction grade on scintigraphy for the parotid gland (P < .001), but not for the submandibular gland. The cutoff value of volume reduction to diagnose severe gland dysfunction was 19.5% (sensitivity, 86.0%; specificity, 100%) for the parotid gland and 31.0% (sensitivity, 100%; specificity, 97.0%) for the submandibular gland, and that of the attenuation change was 9.8 HU (sensitivity, 81.0%; specificity, 95%) for the parotid gland.
CONCLUSIONS: The reduction in volume of the parotid and submandibular glands and the increase in attenuation of the parotid gland on nonenhanced CT can be indicators of the grade of RIT-induced salivary dysfunction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22555571      PMCID: PMC7964601          DOI: 10.3174/ajnr.A3063

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  17 in total

Review 1.  The role of radioactive iodine in salivary gland dysfunction.

Authors:  K A Newkirk; M D Ringel; L Wartofsky; K D Burman
Journal:  Ear Nose Throat J       Date:  2000-06       Impact factor: 1.697

Review 2.  Radioactive iodine and the salivary glands.

Authors:  Susan J Mandel; Louis Mandel
Journal:  Thyroid       Date:  2003-03       Impact factor: 6.568

3.  Spatial and dosimetric variability of organs at risk in head-and-neck intensity-modulated radiotherapy.

Authors:  James L Robar; Allan Day; James Clancey; Robin Kelly; Mammo Yewondwossen; Helmut Hollenhorst; Murali Rajaraman; Derek Wilke
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-29       Impact factor: 7.038

4.  Radiation-induced parotid gland changes in oral cancer patients: correlation between parotid volume and saliva production.

Authors:  Keiko Teshima; Ryuji Murakami; Etsuji Tomitaka; Tomoko Nomura; Ryo Toya; Akimitsu Hiraki; Hideki Nakayama; Toshinori Hirai; Masanori Shinohara; Natsuo Oya; Yasuyuki Yamashita
Journal:  Jpn J Clin Oncol       Date:  2009-10-06       Impact factor: 3.019

5.  Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer.

Authors:  Juliana Pereira Almeida; Alvaro Enrique Sanabria; Eduardo Nóbrega Pereira Lima; Luiz Paulo Kowalski
Journal:  Head Neck       Date:  2010-11-10       Impact factor: 3.147

6.  Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy.

Authors:  Hasan Raza; Aakif U Khan; Abid Hameed; Ayub Khan
Journal:  Nucl Med Commun       Date:  2006-06       Impact factor: 1.690

7.  Computed tomography of the major salivary glands.

Authors:  R N Bryan; R H Miller; R I Ferreyro; R B Sessions
Journal:  AJR Am J Roentgenol       Date:  1982-09       Impact factor: 3.959

8.  Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma.

Authors:  C Alexander; J B Bader; A Schaefer; C Finke; C M Kirsch
Journal:  J Nucl Med       Date:  1998-09       Impact factor: 10.057

9.  Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.

Authors:  Zhong-He Wang; Chao Yan; Zhi-Yuan Zhang; Chen-Ping Zhang; Hai-Sheng Hu; Jessica Kirwan; William M Mendenhall
Journal:  Laryngoscope       Date:  2009-10       Impact factor: 3.325

10.  Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment.

Authors:  Meltem Caglar; Murat Tuncel; Reha Alpar
Journal:  Clin Nucl Med       Date:  2002-11       Impact factor: 7.794

View more
  4 in total

1.  Intravoxel incoherent motion MR imaging measurements of the bilateral parotid glands at 3.0-T MR: effect of age, gender and laterality in healthy adults.

Authors:  Xiao-Quan Xu; Guo-Yi Su; Jun Liu; Hao Hu; Xun-Ning Hong; Hai-Bin Shi; Fei-Yun Wu
Journal:  Br J Radiol       Date:  2015-10-09       Impact factor: 3.039

Review 2.  Imaging of sialadenitis.

Authors:  Ahmed Abdel Khalek Abdel Razek; Suresh Mukherji
Journal:  Neuroradiol J       Date:  2017-01-06

Review 3.  Sialadenitis as a complication of radioiodine therapy in patients with thyroid cancer: where do we stand?

Authors:  Marios Adramerinas; Dimitrios Andreadis; Konstantinos Vahtsevanos; Athanasios Poulopoulos; Kalliopi Pazaitou-Panayiotou
Journal:  Hormones (Athens)       Date:  2021-06-18       Impact factor: 2.885

Review 4.  Radioactive Iodine Therapy and Glucose Tolerance.

Authors:  Roghaieh Samadi; Babak Shafiei; Fereidoun Azizi; Asghar Ghasemi
Journal:  Cell J       Date:  2017-02-22       Impact factor: 2.479

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.